Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study
Umeå Univ, Dept Surg & Perioperat Sci, Umeå, Sweden; Sundsvall Hosp, Dept Oncol, Sundsvall, Sweden.
Umeå Univ, Dept Surg & Perioperat Sci, Umeå, Sweden; Sundsvall Hosp, Dept Surg, Sundsvall, Sweden.
Regional Cancer Center, Uppsala University/ Uppsala University Hospital.ORCID iD: 0000-0001-7181-7083
Umeå Univ, Dept Radiat Sci, Umeå, Sweden.
Show others and affiliations
2021 (English)In: npj Breast Cancer, E-ISSN 2374-4677, Vol. 7, no 1, article id 71Article in journal (Refereed) Published
Abstract [en]

Adjuvant radiotherapy (RT) for breast cancer (BC) has been associated with an increased risk of later radiation-induced lung cancer (LC). We examined the risk of primary LC in a population-based cohort of 52300 women treated for BC during 1992 to 2012, and 253796 age-matched women without BC. Cumulative incidence of LC was calculated by the Kaplan-Meier method, and the risk of LC after BC treatment was estimated by Cox proportional hazards regression analyses. Women with BC receiving RT had a higher cumulative incidence of LC compared to women with BC not receiving RT and women without BC. This became apparent 5 years after RT and increased with longer follow-up. Women with BC receiving RT had a Hazard ratio of 1.59 (95% confidence interval 1.37-1.84) for LC compared to women without BC. RT techniques that lower the incidental lung doses, e.g breathing adaption techniques, may lower this risk.

Place, publisher, year, edition, pages
Springer Nature, 2021. Vol. 7, no 1, article id 71
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-447956DOI: 10.1038/s41523-021-00280-2ISI: 000660692900002PubMedID: 34075042OAI: oai:DiVA.org:uu-447956DiVA, id: diva2:1576480
Funder
The Breast Cancer FoundationVisare Norr, 750491Available from: 2021-07-01 Created: 2021-07-01 Last updated: 2024-01-15Bibliographically approved

Open Access in DiVA

fulltext(834 kB)178 downloads
File information
File name FULLTEXT01.pdfFile size 834 kBChecksum SHA-512
9e64cc9927afa1ee2fdd704b270e355fd24f517583e70b2ed97a335e8a2a58140efc81c308a7aa9eae3f31eb1fa674e5893318cadfb51d4540ef6787b69c60d6
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Garmo, HansHolmberg, LarsNilsson, Greger

Search in DiVA

By author/editor
Garmo, HansHolmberg, LarsNilsson, Greger
By organisation
Endocrine SurgeryExperimental and Clinical Oncology
In the same journal
npj Breast Cancer
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 178 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 102 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf